OBJECTIVE:: To evaluate the hypothesis of stimulant medication effect on physical growth
in the follow-up phase of the Multimodal Treatment Study of Children With ADHD. METHOD:: …

Background The Multimodal Treatment Study ( MTA ) began as a 14‐month randomized
clinical trial of behavioral and pharmacological treatments of 579 children (7–10 years of age) …

OBJECTIVE: To report on the safety and tolerability of methylphenidate (MPH) 3- to 5-year-old
children with attention-deficit/hyperactivity disorder (ADHD) during 1 year of treatment. …

Objective To compare educational, occupational, legal, emotional, substance use disorder,
and sexual behavior outcomes in young adults with persistent and desistent attention-deficit/…

OBJECTIVE: To investigate growth of children with attention-deficit/hyperactivity disorder (ADHD)
in the Preschool ADHD Treatment Study (PATS) before and after initiation of treatment …

OBJECTIVE: To describe the clinical course of attention-deficit/hyperactivity disorder (ADHD)
symptom severity and diagnosis from ages 3 to 5 up to 9 to 12 years during a 6-year follow-…

Objective Longitudinal studies of children diagnosed with ADHD report widely ranging ADHD
persistence rates in adulthood (5–75%). This study documents how information source (…

Objective: Adolescents and young adults without childhood attention deficit hyperactivity
disorder (ADHD) often present to clinics seeking stimulant medication for late-onset ADHD …

Background Inconsistent findings exist regarding long‐term substance use (SU) risk for children
diagnosed with attention‐deficit/hyperactivity disorder (ADHD). The observational follow…

Importance Possible associations between stimulant treatment of attention-deficit/hyperactivity
disorder (ADHD) and subsequent substance use remain debated and clinically relevant. …